Publication Date: September 26, 2024 Published By: Pharmacy Times Article Link: https://www.pharmacytimes.com/view/pharmacy-focus—oncology-edition-advancing-brain-cancer-research-and-treatment Pharmacy Times’ Assistant Editor Kennedy Ferruggia sat down with Dr. Thomas Chen to discuss his work on NeOnc’s nasal delivery system for chemotherapeutics. In the podcast they examine how NeOnc, Inc. is developing innovative intranasal drug delivery methods to bypass the blood-brain barrier […]

Publication Date: September 8, 2024 Published By: El Decano De Guadalajara Article Link: https://eldecanodeguadalajara.com/ Ya sea que un medicamento para el cancer cerebral entre al cuerpo a traves de una aguja en el brazo o se trague, la barrera hematoencefalica se erige como un formidable ultimo obstaculo en el camino de la terapia hacia su […]

Publication Date: September 8, 2024 Published By: Med City News Article Link: https://medcitynews.com/2024/09/biotech-ipo-direct-listing-neonc-brain-cancer-glioblastoma-intranasal-poh/#:~:text=BioPharma-,A%20Biotech%20Going%20Through%20the%20Nose%20to%20Treat%20the%20Brain,intranasally%20administered%20brain%20cancer%20drug. NeOnc Technologies is preparing to go public via the less common path of a direct listing as it continues mid-stage testing of its intranasally administered brain cancer drug. Meanwhile, the mostly stagnant biotech IPO pipeline is showing new signs of life with […]